PRF Technologies Ltd.

PRFX Biotech & pharma

Develops extended-release pain relief drugs for post-surgical patients.

Dec 2025Revenue $17.0K/yrExpenses $5.14M/yr
No trendCash runway ≈ 9 months from Dec 2025
Figures by year

When will PRF Technologies be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $17.0K and expenses $5.14M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$17.0K$5.14M−$5.12M
Dec 2024$0.00$14.7M−$14.7M
Dec 2023$0.00$9.58M−$9.58M